Login to Your Account



Prosonix Adds New Investor, Raises $9M for Inhaled Drugs

By Nuala Moran
Staff Writer

Wednesday, May 23, 2012
LONDON – Particle engineering specialist Prosonix Ltd. has raised a further £5.7 million (US$9 million) in a second closing of Series B funding, taking the total for the round to £17.1 million.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription